Schneider Phillip M is a director of ARS Pharmaceuticals Inc.
Person profile
Roles
ARS Pharmaceuticals
Director
Longboard Pharmaceuticals
Director
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ARS Pharmaceuticals, Inc.
28 Jun 23
4
Longboard Pharmaceuticals, Inc.
26 May 23
4
ARS Pharmaceuticals, Inc.
10 Nov 22
3
ARS Pharmaceuticals, Inc.
10 Nov 22
4
Longboard Pharmaceuticals, Inc.
31 May 22
3
Longboard Pharmaceuticals, Inc.
11 Mar 21
4
Pfenex Inc.
5 Oct 20
4
Pfenex Inc.
11 May 20
4
Pfenex Inc.
10 May 19
4
Pfenex Inc.
13 Sep 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jun 23 | SPRY ARS Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 6.5 | 40,000 | 260.00 k | 40,000 |
25 May 23 | LBPH Longboard Pharmaceuticals | Stock Option Voting common stock | Grant | Acquire A | No | No | 7.06 | 12,500 | 88.25 k | 12,500 |
8 Nov 22 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 1.44 | 76,823 | 110.63 k | 76,823 |
8 Nov 22 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 0.84 | 153,647 | 129.06 k | 153,647 |